• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SenesTech's Evolve™ Rodent Birth Control Proven in Urban Rodent Hotspots from Hong Kong to San Francisco

    6/26/25 8:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials
    Get the next $SNES alert in real time by email

    Pallet and Container Orders Expected for Resupply and Expansion

    SURPRISE, Ariz., June 26, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a leader in fertility control for managing animal pest populations, today announced compelling results from two major urban deployments — one in Hong Kong and one in San Francisco — showing how pairing Evolve™ Rat Birth Control with traditional poison bait stations delivers faster, more sustainable rodent control where it's needed most.

    SenesTech, Inc. is a pioneer in fertility control solutions for managing rodent populations. (PRNewsfoto/SenesTech, Inc.)

    Global Cities Face Persistent Rodent Pressure

    Urban centers worldwide face constant rodent challenges due to dense infrastructure, hard-to-access breeding sites, and abundant food sources. Even the most aggressive traditional rodenticide programs often fall short over time, as rodents adapt to poisons and continue to reproduce unchecked.

    A Breakthrough: Combining Fertility Control with Traditional Rodenticides

    In both Hong Kong and San Francisco, pest management teams implemented a novel integrated strategy: deploying Evolve's palatable soft bait alongside conventional rodenticide blocks within standard bait stations across infested buildings and surrounding areas.

    This hybrid approach tackles two critical issues simultaneously:

    • Immediate population knockdown via targeted poison baiting
    • Long-term population suppression by disrupting rodent reproduction cycles with fertility control

    In Hong Kong, this method was applied in a high-density mixed-use building with persistent rodent activity. Within three months, sightings fell dramatically, bait consumption declined as the population shrank, and no new litters were detected — breaking the cycle of reinfestation that had frustrated property managers for years.

    Further details on this study can be read here.

    In San Francisco, an urban deployment in a heavily trafficked neighborhood known for recurring infestations achieved similar success: a clear reduction in visible rodent activity, less poison used overall, and a measurable drop in new rodent births.

    A New Industry Standard for Sustainable Urban IPM

    "These successes prove that fertility control isn't just an idea — it's a practical tool that helps pest professionals get ahead of chronic infestations faster and with less rodenticide. Deploying Evolve alongside bait blocks strengthens any IPM program. Cities worldwide can benefit from this smarter, more sustainable approach," said Joel Fruendt, CEO of SenesTech. "These kinds of validating results are also what trigger rapid expansion – we are currently preparing for a container-sized order from Hong Kong, for example."

    Delivering Value to Investors and Operators

    Fertility control solutions like Evolve align with changing environmental regulations and public demand for humane, low-toxicity pest management. For pest control professionals and property owners, this means improved outcomes, new service offerings, and better ROI from each deployment. For investors, it signals a rapidly growing global market for next-generation rodent control solutions that complement and enhance traditional tools.

    About SenesTech

    We are committed to improving the health of the world by humanely managing animal pest populations through our expertise in fertility control. We invented ContraPest®, the only U.S. EPA-registered contraceptive for male and female rats, as well as Evolve™ Rat and Evolve™ Mouse, EPA-designated minimum risk contraceptives for rodents, reflecting our mission to provide products that are proactive, safe and sustainable. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. We strive for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable.

    For more information visit https://senestech.com/.

    Safe Harbor Statement

    This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our belief that pairing Evolve with traditional poison bait stations delivers faster, more sustainable rodent control where it's needed most; our belief that fertility control is a practical tool that helps pest professionals get ahead of chronic infestations faster and with less rodenticide; our belief that deploying Evolve alongside bait blocks strengthens any IPM program; our belief that cities worldwide can benefit from this smarter, more sustainable approach; our belief that fertility control solutions like Evolve align with changing environmental regulations and public demand for humane, low-toxicity pest management, meaning improved outcomes, new service offerings, and better ROI from each deployment for pest control professionals and property owners, and signaling to investors a rapidly growing global market for next-generation rodent control solutions that complement and enhance traditional tools. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products, market acceptance of our products, regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

    Contact Information:

    Investors:

    Robert Blum, Lytham Partners, LLC

    (602) 889-9700

    [email protected]

    Marketing:

    Rochelle Paulet, Director of Marketing, SenesTech, Inc.

    (928) 779-4143 x814

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/senestechs-evolve-rodent-birth-control-proven-in-urban-rodent-hotspots-from-hong-kong-to-san-francisco-302491716.html

    SOURCE SenesTech, Inc.

    Get the next $SNES alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNES

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SNES
    SEC Filings

    View All

    SEC Form EFFECT filed by SenesTech Inc.

    EFFECT - SenesTech, Inc. (0001680378) (Filer)

    8/25/25 12:15:30 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form 424B3 filed by SenesTech Inc.

    424B3 - SenesTech, Inc. (0001680378) (Filer)

    8/22/25 4:16:35 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form S-3 filed by SenesTech Inc.

    S-3 - SenesTech, Inc. (0001680378) (Filer)

    8/15/25 4:24:01 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SenesTech to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025

    SURPRISE, Ariz., Aug. 18, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcast presentation at the Lytham Partners 2025 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 19, 2025. The webcast will take place at 3:30 p.m. ET on Tuesday, August 19, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/cts2025/ or directly at https://lythampartners.com/cts2025/snes. A replay will also

    8/18/25 4:15:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins

    94% Revenue Growth in Evolve™ Rodent Birth Control Products Strong Cash Balance and Sustained Progress Toward Profitability SURPRISE, Ariz., Aug. 7, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the second quarter ended June 30, 2025. Q2 2025 Highlights Revenues increased 36% to $625,000, a record for the Company, from $459,000 in Q2 2024.Evolve Rodent Birth Control products sales grew 94%

    8/7/25 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces Closing of Warrant Exercise for $6.3 Million in Gross Proceeds

    SURPRISE, Ariz., Aug. 5, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a leader in fertility control for managing animal pest populations, announced today the closing of its previously announced exercise of certain outstanding warrants to purchase an aggregate of 1,458,872 shares of the Company's common stock originally issued by the Company on July 1, 2025, at the existing exercise price of $4.15 per share. H.C. Wainwright acted as the exclusive placement agent for the transaction. As consideration for the exercise of such existing

    8/5/25 7:10:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Graham Lynn Yako claimed no ownership of stock in the company (SEC Form 3)

    3 - SenesTech, Inc. (0001680378) (Issuer)

    8/14/25 5:09:06 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Director Moss Joshua Matthew

    4 - SenesTech, Inc. (0001680378) (Issuer)

    1/10/25 4:44:49 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    New insider Moss Joshua Matthew claimed no ownership of stock in the company (SEC Form 3)

    3 - SenesTech, Inc. (0001680378) (Issuer)

    1/10/25 4:41:13 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Leadership Updates

    Live Leadership Updates

    View All

    SenesTech Names Nicole Williams as Chief Revenue Officer

    PHOENIX, Feb. 16, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the appointment of Nicole Williams as Chief Revenue Officer. Ms. Williams was previously Chief Strategy Officer, and this appointment is part of an expansion and restructuring of the sales organization and commercialization efforts. The restructuring of the team comes after yet another quarter and fiscal ye

    2/16/23 9:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces Appointment of Vector and Pest Control Industry Veteran Joel Fruendt as Chief Executive Officer

    PHOENIX, Nov. 14, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the appointment of Joel Fruendt as SenesTech's new Chief Executive Officer, succeeding Ken Siegel. Mr. Siegel, who is expected to retire at the end of the year, will remain as an Executive Director, in a consultative role, through the transition period. This leadership transition is part of SenesTech's ongoing strategic plan to drive the commercialization of ContraPest, its flagship product.

    11/14/22 9:10:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:12:23 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G filed by SenesTech Inc.

    SC 13G - SenesTech, Inc. (0001680378) (Subject)

    11/12/24 4:30:48 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Financials

    Live finance-specific insights

    View All

    SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins

    94% Revenue Growth in Evolve™ Rodent Birth Control Products Strong Cash Balance and Sustained Progress Toward Profitability SURPRISE, Ariz., Aug. 7, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the second quarter ended June 30, 2025. Q2 2025 Highlights Revenues increased 36% to $625,000, a record for the Company, from $459,000 in Q2 2024.Evolve Rodent Birth Control products sales grew 94%

    8/7/25 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

    Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, July 31, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in fertility control for managing animal pest populations, will report second quarter 2025 financial results for the period ended June 30, 2025, after the market close on Thursday, August 7, 2025. The Company has scheduled a conference call that same day, Thursday, August 7, 2025, at 5:00 p.m. Eastern time, to review the results. Second Quarter 2025 Conference Call Details Date and Time: Th

    7/31/25 4:15:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Reports First Quarter 2025 Financial Results 40% Revenue Growth in Evolve™, Record Gross Profit Margins of 65%, and Continued Progress Toward Profitability

    SURPRISE, Ariz., May 8, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the first quarter ended March 31, 2024. Q1 2025 Highlights Revenues increased 17% to $485,000 from $415,000 in Q1 2024.Evolve product sales grew 40% year-over-year, now representing 79% of total revenue.Gross profit margin expanded to 64.5%, a record for the Company, compared to 32.5% in Q1 2024.Net loss for Q1 2025 was

    5/8/25 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials